Introduction
CLtrzdidu spp. have emerged as important causes of nosocomial infections. ' The rise in life-threatening opportunist mycoses reflects the increase in high-risk immunocompromised hosts, including immunodeficiency virus-infected individuals,6-8 patients undergoing kidney or bone marrow transplantati~n,~-ll or those with cancer.'"-'" Among opportunist mycoses, Cmdidu spp. are now the fourth most commonly isolated organisms in blood cultures. C. albicans accounts for 60-80 O/ O of isolates, whereas less pathogenic Candidu spp. including C. stellatoidea, C.
tropiutlis, C. kriisei and C. ylabrata account for the remaining clinical specimens.'. l o * *' The importance of non-albicans Cundida spp. is due to their increasing frequency, the emerging tolerance or resistance to antiniycotic agents, as well as the higher mortality associated with their infections.". "-"
C'aridida spp. show a wide range of infectious capabilities. Thus, the infections can vary from superficial mucosal lesions to multiple visceral organ inReceited 6 Dec 1994; revised version accepted 30 March 1995. volvement. The gravest complication of candida infections is disseminated disease resulting in clinical entities such as endocarditis, pyelonephritis, endophthalmitis, osteomyelitis or chronic mucocutaneous infections . 20- 25 The pathogenesis of these lesions is not completely understood, but is known to involve adherence to endothelial and epithelial cells as well as to herence to ECM represents a crucial step in the development of candidosis and is considered a significant virulence factor for these fungi, as the ability of Candida spp. to bind ECM proteins correlates with their relative pathogenicity . 36- 38 Among the molecules involved in cell adhesion to ECM proteins, integrins are a supergene family of highly conserved receptors that mediate cell-matrix and cell-cell interactions in embryogenesis, haemostasis, wound healing, tumour invasion, immune responses, inflammation and infectious diseases. 39 The present study was undertaken to investigate the expression of the asp1 integrin and its functional role in mediating the adhesive interaction of FN with less pathogenic Candida spp.
A better understanding of the mechanisms by which Candida spp. adhere to ECM proteins may be useful in the development of new therapeutic strategies to prevent disseminated infections.
Materials and methods
Candida spp.
C. tropicalis (two clinical isolates), C. stellatoidea (two isolates), C. glabrata (two isolates) and C. krusei (two isolates) were identified by the API 20C system in the Microbiology and Immunology Laboratory of the University of South Florida, Tampa, FL, USA. Yeasts were cultured in Sabouraud's Dextrose Agar (Unipath) and frozen at -80°C in small volumes in Saboraud broth containing glycerol 5 YO until use. For assays, a loopful of yeasts was placed in 50ml of Saboraud dextrose broth and incubated with shaking at 26°C for 20 h. Yeast cells were washed twice with cold PBS by centrifugation at 3000rpm for lOmin, pelleted and examined microscopically to exclude the presence of germ-tube or pseudohyphal phases. All isolates were tested for their ability to adhere to FN and found to be equivalent. Therefore, one isolate of each Candida spp. was used in all the experiments.
Antibodies
The following mouse monoclonal antibodies (MAbs) were used: a n t i d , . Purified FITC-conjugated goat F(ab'), fragment anti-mouse (GaM), and anti-rabbit Ig (GaR), rabbit F(ab'), fragment anti-goat Ig (RaG) were purchased from Cappel Laboratories.
Adhesive proteins and peptides
Human plasma FN was purchased from Gibco Laboratories (Grand Island, NY, USA). The 120-kDa FN proteolytic fragment was obtained from Calbiochem Corp. Substrate preparations were > 95% pure as checked by SDS-PAGE. The GRGDSP and GRGESP peptides were purchased from Telios Pharmaceuticals Inc.
Imrnunoj-luorescence and j-lo w cy tome try
Aliquots of lo6 yeast cells were incubated with a saturating dose of the first antibody for 30 min at 4°C and then washed twice with cold PBS. Cells were incubated with the FITC-conjugated second antibody for 30 min at 4OC, washed twice and resuspended in PBS. Second-step reagents as well as irrelevant isotype-matched MAb plus GaM were used as negative controls. Cells were analysed for relative fluorescence intensity and the percentage of positively stained cells was determined over 10000 events on a FACScan cytofluorimeter (Becton Dickinson, Mountain View, CA, USA). Fluorescence intensity is expressed in arbitrary units on a logarithmic scale. The results are presented both as mean fluorescence intensity (MFI) and percentage of positive cells. Positive yeast cells exhibited an increase in fluorescence intensity above autofluorescence, and the signal from negative cells was not greater than that of the autofluorescence control.
Labelling of Candida spp.
Yeast cells (10') were labelled with 25 pCi of 3H-glucose (Glucose D-(5,6-3H), specific activity 66.6 Ci/mmol ; Dupont Comp. Biotechnology, Wilmington, DE, USA) in 2-5ml of PBS supplemented with 0.5 mM CaCl, and MgCl, for 3 h at room temperature as described previously. 46 After labelling, yeast cells were washed three times in cold PBS to remove free isotope, counted and adjusted to a concentration of 5 x 106/ml in PBS supplemented with 0.5 mM CaCl, and MgCl,.
Adhrsion assajt
Stock preparations of human plasma FN and its proteolytic 120-kDa fragment were diluted in PBS, pH 7.4, at a concentration of 25 pg/ml, which has been detennined previously to be optimal (data not shown). Protein solution (100 pl) was distributed in 96-well tissue culture flat-bottomed plates (Costar, Cambridge, MA, USA). After overnight incubation at 4OC, the coated plates were washed three times with PBS to remove unbound protein. Labelled yeast cells (5 x 10') of each representative isolate of Candida spp. were allowed to adhere to the protein-coated surface for 30 min at 37°C in CO, 5%. Optimal cell concentrations for all Candida spp. were determined by dose-response experiments (data not shown). Adhesion was verified microscopically ; yeast phase was maintained throughout the adhesion assay and agglutination was not observed.
Unattached cells were removed by extensive washing with warm PBS and adherent cells were harvested by adding 1 0 0~1 of Trypsin-EDTA (Flow Laboratories) solubilised in 0.5 M NaOH for 10 min at 37°C. Bound cpni as well as cpm from non-adherent cells plus washes were quantitated in a Wallac Pharmacia 14 10, Dscintillation counter. Quadruplicate wells were assayed for each sample.
To rule out the contribution of yeast cell binding to plastics in the adhesion to FN, assays were always performed in the presence of saturating doses of anti-FN antibodies. which completely abolished cell binding to FN, while not affecting attachment to the plastic surface as described previously."
Total adhesion was calculated according to the following formula : cpm (adherent cells)/total cpm x 100, where total cpm indicates the sum of nonadherent cells, washes and adherent cells cpm. This value routinely exceeded 93 O/ O of total cell counts.
Specific binding to FN was calculated as the difference between total percentage adhesion and percentage adhesion not inhibited by anti-FN antibody (non-specific adhesion). Non-specific cell adhesion never exceeded 10 O/O.
For inhibition of the adhesion of Candida spp. to FN, binding assays were performed following pretreatment of radiolabelled yeast cells for 30 min with a rabbit or a goat anti-FNr antiserum, anti-a5 SAM-1 or PID6 MAb, control antibody including normal goat IgG, rabbit IgG, and an anti-glucomannoprotein MAb or with different concentrations of GRGDSP and GRGESP peptides.
St at is t ical anulvs is
by the STATPAC computerised program.
Statistical analysis by Student's t test was performed

Results
Expression of u receptor antigenically related to asp1
integrin by diyerent Candida spp.
Adherence of Candida spp. to FN has been reported previoUsly,30. 31,35,42.43 but the molecular basis of this interaction has not yet been clearly defined. In an attempt to investigate the receptors involved in the specific adhesion of less pathogenic Candida spp. to FN, the expression of the FNr prototype, a5pl integrin, was evaluated on C. tropicalis, C. Reactivity of a n t i d (clones SAM-1 and PlD6), anti-p1 (clones 4B4 and AlA5) MAb, goat (GaFNr) and rabbit (RaFNr) anti-FNr antisera with C . tropicalis, C. stellatoidea, C. glabrata and C. krusei was evaluated by indirect immunofluorescence and flow cytometric analysis. *Mean fluorescence intensity (MFI) data are the means of four separate experiments and SD. MFI was calculated as the ratio between the MFI of the experimental group and MFI of the control (second-step reagent alone).
Adhesion of Candida spp. yeast cells to the 120-kDa proteolytic fragment of FN
of the FN molecule.41 To investigate the possible involvement of a5pl in these interactions, the adhesion
The mechanisms involved in the adhesion of different Candida spp. to FN were investigated further by testing the ability of C. tropicalis, C. stellatoidea, C. glabrata and C. krusei to specifically adhere to the 120-kDa FN proteolytic fragment which contains the RGDS cell binding site4' (fig. 3) . C. tropicalis, C. glabrata and C. stellatoidea bound to FN as well as its 120-kDa fragment, C. tropicalis being the most adhesive species. As observed with the entire FN molecule, C. krusei did not significantly bind to the 120-kDa FN fragment. assay was performed in the presence of an RGDcontaining peptide (fig. 4) . Pre-treatment of C. tropicalis, C. stellatoidea and C. glabrata yeast cells with different doses of GRGDSP peptide partially inhibited the adhesion to FN in a dose-dependent manner, with the highest inhibition found for C. tropicalis. No inhibition was observed in the presence of different doses of the control peptide GRGESP. These results indicate that adhesion of less pathogenic Candida spp. to FN is mediated by RGD-containing peptides.
Inhibition of Candida spp. adhesion to FN by RGD-containing peptides
Studies on mammalian cells have shown that a5pl recognises the RGDS binding site in the central region
Inhibition of Candida spp. adhesion to FN by anti-a5, or an ti-FNr antibodies
The possible involvement of a5pl integrin in the adhesion of C. tropicalis, C. stellatoidea and C. C. tropcalis C. stellatoidea C. glabrata C. krusei step in the development of candidosis. Both yeast and germ-tube phases of C. albicans express a functional FNr antigenically related to a5p1, that is up-regulated during germ-tube transition and mediates adhesion to FN of both Candida phases. 43 The results of the present study indicate that yeast forms of less pathogenic Candida spp., including C. tropicalis, C. stellatoidea, C. glabrata, but not C. krusei, also express a surface receptor that shares antigenic homology with the a5pl integrin and mediates adhesion to FN. Flow cytometric analysis indicates that certain antibodies directed against the human a5 integrin subunit or a5pl heterodimer differentially bind to Candida spp. with C. tropicalis, C. stellatoidea and C. glabrata exhibiting high reactivity and C. krusei reacting only marginally. The expression of asp1 -like integrin directly correlated with the extent of Candida spp. adhesion to FN; 20-30% of C. tropicalis, C. stellatoidea and C. glabrata yeasts specifically bound to FN, whereas C. krusei failed to adhere to this ECM glycoprotein.
The a5pl -like receptor expressed by C. tropicalis, C. stellatoidea and C. glabrata is the primary mediator of adhesion to immobilised FN. The less pathogenic Candida spp. bound to the 120-kDa proteolytic fragment of FN which contains the RGDS sequence recognised by a5p141 and their binding to the entire FN molecule was partially inhibited by GRGDSP, but not GRGESP peptides. More direct evidence that an a5pl-like integrin is involved in the interaction of Candida spp. with FN was obtained by the use of functional antibodies directed against a5 or a5p1 FNr that blocked specific adhesion to FN.
Expression of an FNr antigenically related to a5pl on Candida spp. appears to be particularly significant for their interaction with host tissues such as epithelial or endothelial cells. Involvement of FN in the interaction of C. albicans or C. tropicalis with buccal and vaginal epithelial cells, epidermal keratinocytes or endothelium has been Adhesion of C. albicans germ tubes to cultured human epidermal keratinocytes was partially inhibited by PepTite-2000, an RGD-containing synthetic ~e p t i d e .~~ Similarly, binding of C. tropicalis yeasts to epithelial cells was significantly inhibited by RGD peptides derived from FN but not from inactivated complement receptor type 3 (iC3b), while inverse results were obtained for C. albi~ans.~' Adhesion of C. albicans to endothelium is also RGD-dependent but probably involves more than one integrin receptor as suggested by the possible involvement of iC3b. 51 It is possible that a5pl-like receptors play a major role in the development of candida infection. A FNderived RGD-containing peptide affects the distribution and the fate of intravenously administered C. albicans yeast cells :56 after administration of RGDcontaining peptides, the heart, kidney and liver of treated animals had significantly fewer cfu of fungus and the number of renal abscesses was reduced.
Several animal and experimental models of infection have provided conclusive evidence for a hierarchy of relative virulence among the pathogenic Candida spp. These differences in virulence are closely paralleled by the varying abilities of Candida spp. to bind to epithelial and endothelial cells and complement components, as well as to ECM proteins. Thus, C. albicans attaches to exfoliated vaginal or buccal cells in much greater numbers than C. tropicalis (the next most adherent species), whereas C. krusei shows little or no adhesion.52 Similar species differences have been reported for adhesion to epidermal corne~cytes,~~ and vascular e n d~t h e l i u m .~~~ 55 In addition, mutant strains of C. albicans with reduced ability to adhere to human These results show a correlation between the expression and function of cx5gl integrin-like receptor on C'wrlitlir spp. and the hierarchy of relative virulence among the pathogenic Candida spp. and suggest that the a5Pl analogue may be a significant virulence factor for these fungi. The highest infection capability showed by C. tropicalis directly correlated with the expression and function of asp1 integrin-like receptor. Conversely, the poor infection capability exhibited by C. krusei may be attributable to the failure to express this receptor.
In conclusion, Candidu-host cell interaction, is a multifactorial phenomenon involving different adhesion pathways. An understanding of the molecular basis of these adhesive interactions would enable the development of new therapeutic strategies ; invasive infections may be prevented by specific blockade of fungal adherence receptors with adhesion molecule-based drugs.
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